Clinical Trial Update: Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

View source ↗

Summary

A recruiting clinical trial evaluating biomarkers to assess disease severity in Fontan-associated liver disease, a liver complication seen in patients with sing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fontan-associated Liver Disease

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Congenital Heart Disease | Status: RECRUITING